Welcome!

News Feed Item

Gene Expression Analysis Market by Technology (DNA Microarray, Real-Time PCR, Next Generation Sequencing), Consumables (DNA Chips, Reagents), Services (Gene Profiling, Bioinformatics, Data Analysis Software) & Applications] - Global Forecast to 2018

NEW YORK, Feb. 27, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Gene Expression Analysis Market by Technology (DNA Microarray, Real-Time PCR, Next Generation Sequencing), Consumables (DNA Chips, Reagents), Services (Gene Profiling, Bioinformatics, Data Analysis Software) & Applications] - Global Forecast to 2018
http://www.reportlinker.com/p02038652/Gene-Expression-Analysis-Market-by-Technology-DNA-Microarray-Real-Time-PCR-Next-Generation-Sequencing-Consumables-DNA-Chips-Reagents-Services-Gene-Profiling-Bioinformatics-Data-Analysis-Software--Applications]---Global-Forecast-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics

Over the years, the gene expression analysis market, comprising of instruments, consumables, and services, has witnessed various technological advancements. These advancements have led to a growth in the number of gene expression applications. Some of the applications using gene expression analysis are pharmacogenomics, diagnostics, toxicogenomics, and biomarkers. However, the high cost of instruments and the need for skilled professionals to operate these highly sophisticated systems are factors that are hindering the market.

The services segment is the fastest-growing segment in the gene expression analysis market. The gene expression analysis services market consists of gene expression profiling, bioinformatics solutions, data analysis software, and others. The gene expression profiling services is further segmented into sequencing services, microarray services, and qPCR services. This segment accounts for the largest share in the services segment. The decreasing cost of sequencing and increasing focus on the discovery of new information has increased the demand for sequencing services.

In the years to come, the gene expression analysis market is expected to experience the highest growth in the Asian region with emphasis on China, India, and Japan. These countries will serve as new revenue pockets for companies involved in gene expression analysis market. The high growth in these regions can be attributed to the increased involvement of their respective governments, increased funding scenario, and collaborations with established market players. Apart from Asia, countries such as Brazil, Turkey, and South Africa are also projected to have high growth in the gene expression analysis market. The U.S. and Europe are mature gene expression analysis markets. Increasing research in diseases like cancer, Alzheimer's, and Parkinson's and focus on gene-related discoveries are expected to propel the demand in these regions. RoW includes regions such as Latin America, Africa, the Middle East, and the Pacific countries. These markets are slated to grow at a steady pace. However, with countries in these regions increasing their focus on research and gaining funds, these regions could be considered as potential high-growth regions.

The global gene expression analysis market witnesses high competitive intensity as there are many big and small firms with similar product offerings. These companies adopt various strategies (innovations, acquisitions, and geographic expansions related to endoscopy products) to increase their market shares and to establish a strong foothold in the global market.

The report extensively covers gene expression analysis instruments, consumables, and services.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios and services offered by the top 10 players in the gene expression analysis market. The report analyzes instruments (by technology), consumables, and services

• Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the gene expression analysis market

• Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various gene expression analysis products across geographies

• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the gene expression analysis market

• Competitive Assessment: In-depth assessment of market shares, strategies, products and services, distribution networks, and manufacturing capabilities of leading players in the gene expression analysis market

1 INTRODUCTION 17

1.1 OBJECTIVES OF THE STUDY 17
1.2 REPORT DESCRIPTION 17
1.3 MARKETS COVERED 18
1.4 STAKEHOLDERS 20
1.5 RESEARCH METHODOLOGY 20
1.5.1 SECONDARY RESEARCH 22
1.5.2 PRIMARY RESEARCH 23
1.5.2.1 Key data points from primary sources 24
1.5.3 MARKET SIZE ESTIMATION 24
1.5.4 MARKET FORECAST 27
1.5.5 MARKET DATA VALIDATION & DATA TRIANGULATION 28
1.6 ASSUMPTIONS 29

2 EXECUTIVE SUMMARY 30

3 MARKET OVERVIEW 33

3.1 INTRODUCTION 34
3.2 MARKET DYNAMICS 34
3.2.1 DRIVERS 35
3.2.1.1 Increasing Number of Cancer Patients globally 35
3.2.1.2 Increase in investments, funds, and grants by government bodies worldwide 36
3.2.1.3 Technological advancements 37
3.2.1.4 Small RNAs Gaining momentum 39
3.2.1.5 Gene expression databases to aid cancer research 40
3.2.1.6 Use of microarray technology to aid gene expression studies 40
3.2.1.7 Use of SBS technology to aid more detailed cancer studies 40
3.2.2 RESTRAINTS 41
3.2.2.1 High cost of instruments 41
3.2.2.2 Dearth of technical expertise 41
3.2.3 OPPORTUNITIES 42
3.2.3.1 Rising opportunities in emerging nations 42
3.2.3.2 Growth in personalized medicine (Gene Therapy) 44
3.3 MARKET SHARE ANALYSIS 45
3.3.1 GENE EXPRESSION ANALYSIS MARKET, BY KEY PLAYERS 45
3.4 VALUE CHAIN ANALYSIS 49
3.4.1 SEQUENCING PLATFORMS 49
3.5 GENE EXPRESSION APPLICATION MARKET ANALYSIS 51

4 GENE EXPRESSION ANALYSIS MARKET, BY SEGMENT 52

4.1 INTRODUCTION 53

5 GENE EXPRESSION ANALYSIS INSTRUMENTATION MARKET,
BY TECHNOLOGY 57


5.1 INTRODUCTION 58
5.2 DNA MICROARRAYS 61
5.3 REAL-TIME POLYMERASE CHAIN REACTION (RT-PCR) 62
5.4 NEXT GENERATION SEQUENCING 64
5.5 OTHERS 65
5.5.1 SERIAL ANALYSIS OF GENE EXPRESSION (SAGE) 65
5.5.2 NORTHERN BLOTTING 66

6 GENE EXPRESSION ANALYSIS CONSUMABLES MARKET,
BY PRODUCT 67


6.1 INTRODUCTION 68
6.2 DNA CHIPS 71
6.2.1 OLIGONUCLEOTIDES 72
6.2.2 cDNA 74
6.3 REAGENTS 75

7 GENE EXPRESSION ANALYSIS SERVICES MARKET, BY PRODUCT 77

7.1 INTRODUCTION 77
7.2 GENE EXPRESSION PROFILING SERVICES 80
7.2.1 SEQUENCING SERVICES 81
7.2.2 MICROARRAY SERVICES 83
7.2.3 qPCR SERVICES 84
7.3 BIOINFOMATICS SOLUTIONS 85
7.4 DATA ANALYSIS SOFTWARE 87
7.5 OTHERS 88

8 GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION 90

8.1 INTRODUCTION 91
8.2 DIAGNOSTICS 93
8.3 DRUG DISCOVERY 94
8.4 ACADEMIC RESEARCH 96
8.5 BIOMARKERS 97
8.6 OTHERS 99

9 GEOGRAPHIC ANALYSIS 100

9.1 INTRODUCTION 101
9.2 NORTH AMERICA 106
9.2.1 INCREASED FUNDING FOR MEDICAL RESEARCH 109
9.2.2 INCREASING NUMBER OF CANCER PATIENTS 112
9.2.3 REDUCTION IN THE COST OF SEQUENCING 114
9.3 EUROPE 117
9.3.1 GOVERNMENT SUPPORT, COLLABORATIONS, AND GREENFIELD INVESTMENTS TO TRIGGER MARKET GROWTH IN TURKEY 118
9.3.2 REDUCED GOVERNMENT FUNDING IN EUROPE TO PUT PRESSURE ON SCIENCE AND RESEARCH ACTIVITIES 120
9.3.3 INCREASING FOCUS ON PHARMACOGENOMICS TO BOOST THE GENE EXPRESSION ANALYSIS MARKET IN EUROPE 122
9.3.4 APPROVALS AND DEVELOPMENTS IN GENE THERAPY TO PROPEL GROWTH IN THE EUROPEAN REGION 124
9.3.5 THE SEQUENCING OF 100,000 GENOMES IN THE U.K. TO TRIGGER GROWTH IN THE EUROPEAN REGION 125
9.4 ASIA 127
9.4.1 GROWTH IN THE NUMBER OF CONFERENCES AND EXHIBITIONS ON GENE EXPRESSION TO BOOST THE ASIAN MARKET 128
9.4.2 DOMINANT PRESENCE OF SINGAPORE IN THE GENE EXPRESSION ANALYSIS MARKET 130

9.4.3 GENE EXPRESSION SIGNATURE FOR QUALITY CONTROL OF TRADITIONAL CHINESE MEDICINES 132
9.4.4 ACTIVITIES OF BEIJING GENOMICS INSTITUTE (BGI) LIKELY TO CATAPULT THE CHINESE MARKET 133
9.4.5 COLLABORATIONS BETWEEN ESTABLISHED PLAYERS AND LOCAL ORGANISATIONS IN CHINA TO DRIVE THE MARKET 134
9.4.6 THE RISE OF THE INDIAN GENOMICS MARKET 136
9.4.7 JAPAN'S INCREASING FOCUS ON CANCER RESEARCH 136
9.5 REST OF THE WORLD (ROW) 137
9.5.1 FUNDING SCENARIO IN MIDDLE EAST AND PACIFIC COUNTRIES 138
9.5.2 INCREASING FOCUS ON HIV/AIDS GENETIC RESARCH IN AFRICA 140
9.5.3 FOCUS OF SOUTH AMERICAN COUNTRIES ON GENOMIC RESEARCH TO IMPORVE PUBLIC HEALTH 142
9.5.4 GROWING BRAZILIAN MARKET AND COMMITMENT TO GENE RELATED RESEARCH TO BOOST THE MARKET 143
9.5.5 GROWING NEED OF GENE EXPRESSION PROFILING TO UNDERSTAND AND COMBAT CANCER IN SOUTH AMERICA AND PACIFIC COUNTRIES IS LIKELY TO PROPEL THE MARKET GROWTH 145

10 COMPETITIVE LANDSCAPE 146

10.1 INTRODUCTION 146
10.2 NEW PRODUCT LAUNCH 150
10.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES 151
10.4 MERGERS & ACQUISITIONS 153
10.5 EXPANSION 154
11 COMPANY PROFILES 156
(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 AFFYMETRIX, INC. 156
11.2 AGILENT TECHNOLOGIES 164
11.3 BIO-RAD LABORATORIES, INC. 172
11.4 GE HEALTHCARE (SUBSIDIARY OF GENERAL ELECTRIC COMPANY) 179
11.5 ILLUMINA, INC. 183
11.6 LIFE TECHNOLOGIES 193
11.7 LUMINEX CORPORATION 200
11.8 OXFORD GENE TECHNOLOGY, INC. 204
11.9 PERKINELMER, INC. 210
11.10 QIAGEN N.V. 214
11.11 ROCHE DIAGNOSTICS CORPORATION 219
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

LIST OF TABLES

TABLE 1 SAMPLING FRAME: PRIMARY RESEARCH 23
TABLE 2 GLOBAL GENE EXPRESSION ANALYSIS MARKET, BY SEGMENT,
2011–2018 ($MILLION) 54
TABLE 3 GENE EXPRESSION ANALYSIS MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 55
TABLE 4 GLOBAL GENE EXPRESSION ANALYSIS INSTRUMENTATION MARKET,
BY TECHNOLOGY, 2011–2018 ($MILLION) 59
TABLE 5 GENE EXPRESSION ANALYSIS INSTRUMENTATION MARKET,
BY GEOGRAPHY, 2011–2018 ($MILLION) 60
TABLE 6 DNA MICROARRAY MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 61
TABLE 7 REAL-TIME PCR MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 63
TABLE 8 NEXT-GENERATION SEQUENCINGMARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 64
TABLE 9 OTHERS MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 66
TABLE 10 GLOBAL GENE EXPRESSION ANALYSIS CONSUMABLES MARKET,
BY PRODUCT, 2011–2018 ($MILLION) 69
TABLE 11 GENE EXPRESSION ANALYSIS CONSUMABLES MARKET,
BY GEOGRAPHY, 2011–2018 ($MILLION) 70
TABLE 12 GLOBAL DNA CHIPS MARKET, BY TYPE, 2011–2018 ($MILLION) 71
TABLE 13 DNA CHIPS MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 72
TABLE 14 OLIGONUCLEOTIDES MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 73
TABLE 15 COMPLEMENTARY DNA MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 74
TABLE 16 GENE EXPRESSION ANALYSIS REAGENTS MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 76
TABLE 17 GLOBAL GENE EXPRESSION ANALYSIS SERVICES MARKET,
BY PRODUCT, 2011–2018 ($MILLION) 78

TABLE 18 GENE EXPRESSION ANALYSIS SERVICES MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 79
TABLE 19 GLOBAL GENE EXPRESSION PROFILING SERVICES MARKET,
BY TYPE, 2011–2018 ($MILLION) 80
TABLE 20 GENE EXPRESSION PROFILING SERVICES MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 81
TABLE 21 SEQUENCING SERVICES MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 82
TABLE 22 MICROARRAY SERVICES MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 83
TABLE 23 QPCR SERVICES MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 84
TABLE 24 BIOINFORMATICS SOLUTIONS MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 86
TABLE 25 DATA ANALYSIS SOFTWARE MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 87
TABLE 26 OTHER SERVICES MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 88
TABLE 27 GLOBAL GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2011–2018 ($MILLION) 92
TABLE 28 GENE EXPRESSION ANALYSIS DIAGNOSTICS MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 93
TABLE 29 GENE EXPRESSION ANALYSIS DRUG DISCOVERY MARKET,
BY GEOGRAPHY, 2011–2018 ($MILLION) 95
TABLE 30 GENE EXPRESSION ANALYSIS ACADEMIC RESEARCH MARKET,
BY GEOGRAPHY, 2011–2018 ($MILLION) 96
TABLE 31 GENE EXPRESSION ANALYSIS BIOMARKERS MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 98

TABLE 32 GENE EXPRESSION ANALYSIS OTHERS MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 99
TABLE 33 GENE EXPRESSION ANALYSIS MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 102
TABLE 34 GENE EXPRESSION ANALYSIS INSTRUMENTATION MARKET,
BY GEOGRAPHY, 2011–2018 ($MILLION) 103
TABLE 35 GENE EXPRESSION ANALYSIS CONSUMABLES MARKET,
BY GEOGRAPHY, 2011–2018 ($MILLION) 104
TABLE 36 GENE EXPRESSION ANALYSIS SERVICES MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 105
TABLE 37 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET,
BY SEGMENT, 2011–2018 ($MILLION) 106
TABLE 38 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2011–2018 ($MILLION) 107
TABLE 39 NORTH AMERICA: GENE EXPRESSION ANALYSIS INSTRUMENTATION MARKET, BY COUNTRY, 2011–2018 ($MILLION) 107
TABLE 40 NORTH AMERICA: GENE EXPRESSION ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2011–2018 ($MILLION) 108
TABLE 41 NORTH AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET,
BY COUNTRY, 2011–2018 ($MILLION) 109
TABLE 42 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET,
BY APPLICATION, 2011–2018 ($MILLION) 110
TABLE 43 NORTH AMERICA: GENE EXPRESSION ANALYSIS INSTRUMENTATION MARKET, BY TECHNOLOGY, 2011–2018 ($MILLION) 112
TABLE 44 NORTH AMERICA: GENE EXPRESSION ANALYSIS CONSUMABLES MARKET, BY PRODUCT, 2011–2018 ($MILLION) 113

TABLE 45 NORTH AMERICA: DNA CHIPS MARKET, BY TYPE,
2011–2018 ($MILLION) 114
TABLE 46 NORTH AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET,
BY PRODUCT, 2011–2018 ($MILLION) 115
TABLE 47 NORTH AMERICA: GENE EXPRESSION PROFILING SERVICES MARKET, BY TYPE, 2011–2018 ($MILLION) 116
TABLE 48 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY SEGMENT,
2011–2018 ($MILLION) 117
TABLE 49 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2011–2018 ($MILLION) 119
TABLE 50 EUROPE: GENE EXPRESSION ANALYSIS INSTRUMENTATION MARKET, BY TECHNOLOGY, 2011–2018 ($MILLION) 120
TABLE 51 EUROPE: GENE EXPRESSION ANALYSIS CONSUMABLES MARKET,
BY PRODUCT, 2011–2018 ($MILLION) 121
TABLE 52 EUROPE: DNA CHIPS MARKET, BY TYPE, 2011–2018 ($MILLION) 122
TABLE 53 EUROPE: GENE EXPRESSION ANALYSIS SERVICES MARKET,
BY PRODUCT, 2011–2018 ($MILLION) 123
TABLE 54 EUROPE: GENE EXPRESSION PROFILING SERVICES MARKET,
BY TYPE, 2011–2018 ($MILLION) 125
TABLE 55 ASIA: GENE EXPRESSION ANALYSIS MARKET, BY SEGMENT,
2011–2018 ($MILLION) 127
TABLE 56 ASIA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION,
2011–2018 ($MILLION) 129
TABLE 57 ASIA: GENE EXPRESSION ANALYSIS INSTRUMENTATION MARKET,
BY TECHNOLOGY, 2011–2018 ($MILLION) 130
TABLE 58 ASIA: GENE EXPRESSION ANALYSIS CONSUMABLES MARKET,
BY PRODUCT, 2011–2018 ($MILLION) 131

TABLE 59 ASIA: DNA CHIPS MARKET, BY TYPE, 2011–2018 ($MILLION) 132
TABLE 60 ASIA: GENE EXPRESSION ANALYSIS SERVICES MARKET,
BY PRODUCT, 2011–2018 ($MILLION) 134
TABLE 61 ASIA: GENE EXPRESSION PROFILING SERVICES MARKET,
BY TYPE, 2011–2018 ($MILLION) 135
TABLE 62 ROW: GENE EXPRESSION ANALYSIS MARKET, BY SEGMENT,
2011–2018 ($MILLION) 137
TABLE 63 ROW: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION,
2011–2018 ($MILLION) 139
TABLE 64 ROW: GENE EXPRESSION ANALYSIS INSTRUMENTATION MARKET,
BY TECHNOLOGY, 2011–2018 ($MILLION) 140
TABLE 65 ROW: GENE EXPRESSION ANALYSIS CONSUMABLES MARKET,
BY PRODUCT, 2011–2018 ($MILLION) 141
TABLE 66 ROW: DNA CHIPS MARKET, BY TYPE, 2011–2018 ($MILLION) 142
TABLE 67 ROW: GENE EXPRESSION ANALYSIS SERVICES MARKET,
BY PRODUCT, 2011–2018 ($MILLION) 143
TABLE 68 ROW: GENE EXPRESSION PROFILING SERVICES MARKET,
BY TYPE, 2011–2018 ($MILLION) 144
TABLE 69 NEW PRODUCT LAUNCH (JANUARY 2011–JUNE 2013) 150
TABLE 70 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, CONTRACTS, AND JOINT VENTURES (JANUARY 2011–JUNE 2013) 151
TABLE 71 MERGERS AND ACQUISITIONS (JANUARY 2011–JUNE 2013) 153
TABLE 72 EXPANSION (JANUARY 2011–JUNE 2013) 154

LIST OF FIGURES

FIGURE 1 RESEARCH METHODOLOGY FOR THE GENE EXPRESSION ANALYSIS MARKET 21
FIGURE 2 MARKET SIZE ESTIMATION METHODOLOGY 25
FIGURE 3 MARKET SIZING ($VALUE ANALYSIS) 26
FIGURE 4 COMPETITIVE ASSESSMENT (MARKET SHARE/STRATEGIES ASSESSMENT FOR GENE EXPRESSION ANALYSIS PRODUCTS) 27
FIGURE 5 DATA TRIANGULATION METHODOLOGY 28
FIGURE 6 GENE EXPRESSION ANALYSIS MARKET, BY SEGMENT, 2013 30
FIGURE 7 GENE EXPRESSION ANALYSIS MARKET, 2013 31
FIGURE 8 MARKET DYNAMICS 35
FIGURE 9 MARKET SHARE ANALYSIS, BY KEY PLAYERS 45
FIGURE 10 VALUE CHAIN ANALYSIS FOR SEQUENCING PLATFORMS 49
FIGURE 11 GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION (2013) 51
FIGURE 12 GENE EXPRESSION ANALYSIS MARKET SEGMENTATION 54
FIGURE 13 GENE EXPRESSION ANALYSIS INSTRUMENTATION MARKET,
BY TECHNOLOGY 58
FIGURE 14 GENE EXPRESSION ANALYSIS CONSUMABLES MARKET SEGMENTATION 68
FIGURE 15 GENE EXPRESSION ANALYSIS SERVICES MARKET SEGMENTATION 77
FIGURE 16 GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION 91
FIGURE 17 GENE EXPRESSION ANALYSIS MARKET, GEOGRAPHICAL RANKING, 2013 101
FIGURE 18 KEY GROWTH STRATEGIES IN THE GENE EXPRESSION ANALYSIS MARKET, 2011–2013 146
FIGURE 19 KEY PLAYERS FOCUSING ON THE NEW PRODUCT LAUNCH STRATEGY, 2011–2013 148
FIGURE 20 KEY PLAYERS FOCUSING ON THE STRATEGY OF AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, CONTRACTS, AND JOINT VENTURES, 2011–2013 149

To order this report: Gene Expression Analysis Market by Technology (DNA Microarray, Real-Time PCR, Next Generation Sequencing), Consumables (DNA Chips, Reagents), Services (Gene Profiling, Bioinformatics, Data Analysis Software) & Applications] - Global Forecast to 2018
http://www.reportlinker.com/p02038652/Gene-Expression-Analysis-Market-by-Technology-DNA-Microarray-Real-Time-PCR-Next-Generation-Sequencing-Consumables-DNA-Chips-Reagents-Services-Gene-Profiling-Bioinformatics-Data-Analysis-Software--Applications]---Global-Forecast-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
In his session at 21st Cloud Expo, Raju Shreewastava, founder of Big Data Trunk, provided a fun and simple way to introduce Machine Leaning to anyone and everyone. He solved a machine learning problem and demonstrated an easy way to be able to do machine learning without even coding. Raju Shreewastava is the founder of Big Data Trunk (www.BigDataTrunk.com), a Big Data Training and consulting firm with offices in the United States. He previously led the data warehouse/business intelligence and B...
Blockchain is a shared, secure record of exchange that establishes trust, accountability and transparency across business networks. Supported by the Linux Foundation's open source, open-standards based Hyperledger Project, Blockchain has the potential to improve regulatory compliance, reduce cost as well as advance trade. Are you curious about how Blockchain is built for business? In her session at 21st Cloud Expo, René Bostic, Technical VP of the IBM Cloud Unit in North America, discussed the b...
The past few years have brought a sea change in the way applications are architected, developed, and consumed—increasing both the complexity of testing and the business impact of software failures. How can software testing professionals keep pace with modern application delivery, given the trends that impact both architectures (cloud, microservices, and APIs) and processes (DevOps, agile, and continuous delivery)? This is where continuous testing comes in. D
SYS-CON Events announced today that Synametrics Technologies will exhibit at SYS-CON's 22nd International Cloud Expo®, which will take place on June 5-7, 2018, at the Javits Center in New York, NY. Synametrics Technologies is a privately held company based in Plainsboro, New Jersey that has been providing solutions for the developer community since 1997. Based on the success of its initial product offerings such as WinSQL, Xeams, SynaMan and Syncrify, Synametrics continues to create and hone in...
With tough new regulations coming to Europe on data privacy in May 2018, Calligo will explain why in reality the effect is global and transforms how you consider critical data. EU GDPR fundamentally rewrites the rules for cloud, Big Data and IoT. In his session at 21st Cloud Expo, Adam Ryan, Vice President and General Manager EMEA at Calligo, examined the regulations and provided insight on how it affects technology, challenges the established rules and will usher in new levels of diligence arou...
As you move to the cloud, your network should be efficient, secure, and easy to manage. An enterprise adopting a hybrid or public cloud needs systems and tools that provide: Agility: ability to deliver applications and services faster, even in complex hybrid environments Easier manageability: enable reliable connectivity with complete oversight as the data center network evolves Greater efficiency: eliminate wasted effort while reducing errors and optimize asset utilization Security: imple...
Nordstrom is transforming the way that they do business and the cloud is the key to enabling speed and hyper personalized customer experiences. In his session at 21st Cloud Expo, Ken Schow, VP of Engineering at Nordstrom, discussed some of the key learnings and common pitfalls of large enterprises moving to the cloud. This includes strategies around choosing a cloud provider(s), architecture, and lessons learned. In addition, he covered some of the best practices for structured team migration an...
Mobile device usage has increased exponentially during the past several years, as consumers rely on handhelds for everything from news and weather to banking and purchases. What can we expect in the next few years? The way in which we interact with our devices will fundamentally change, as businesses leverage Artificial Intelligence. We already see this taking shape as businesses leverage AI for cost savings and customer responsiveness. This trend will continue, as AI is used for more sophistica...
The 22nd International Cloud Expo | 1st DXWorld Expo has announced that its Call for Papers is open. Cloud Expo | DXWorld Expo, to be held June 5-7, 2018, at the Javits Center in New York, NY, brings together Cloud Computing, Digital Transformation, Big Data, Internet of Things, DevOps, Machine Learning and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding busin...
No hype cycles or predictions of a gazillion things here. IoT is here. You get it. You know your business and have great ideas for a business transformation strategy. What comes next? Time to make it happen. In his session at @ThingsExpo, Jay Mason, an Associate Partner of Analytics, IoT & Cybersecurity at M&S Consulting, presented a step-by-step plan to develop your technology implementation strategy. He also discussed the evaluation of communication standards and IoT messaging protocols, data...
Companies are harnessing data in ways we once associated with science fiction. Analysts have access to a plethora of visualization and reporting tools, but considering the vast amount of data businesses collect and limitations of CPUs, end users are forced to design their structures and systems with limitations. Until now. As the cloud toolkit to analyze data has evolved, GPUs have stepped in to massively parallel SQL, visualization and machine learning.
Modern software design has fundamentally changed how we manage applications, causing many to turn to containers as the new virtual machine for resource management. As container adoption grows beyond stateless applications to stateful workloads, the need for persistent storage is foundational - something customers routinely cite as a top pain point. In his session at @DevOpsSummit at 21st Cloud Expo, Bill Borsari, Head of Systems Engineering at Datera, explored how organizations can reap the bene...
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, led attendees through the exciting evolution of the cloud. He looked at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering m...
In his session at 21st Cloud Expo, Michael Burley, a Senior Business Development Executive in IT Services at NetApp, described how NetApp designed a three-year program of work to migrate 25PB of a major telco's enterprise data to a new STaaS platform, and then secured a long-term contract to manage and operate the platform. This significant program blended the best of NetApp’s solutions and services capabilities to enable this telco’s successful adoption of private cloud storage and launching ...
Kubernetes is an open source system for automating deployment, scaling, and management of containerized applications. Kubernetes was originally built by Google, leveraging years of experience with managing container workloads, and is now a Cloud Native Compute Foundation (CNCF) project. Kubernetes has been widely adopted by the community, supported on all major public and private cloud providers, and is gaining rapid adoption in enterprises. However, Kubernetes may seem intimidating and complex ...